MetaSight Diagnostics
Revolutionizing Liquid Biopsy
StartupMetaSight Diagnostics is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2020. Revolutionizing Liquid Biopsy. The company has raised a total of $8M across 2 funding rounds, currently at the A stage. MetaSight Diagnostics was founded by Tomer Shlomi. Key investors include Saban Ventures, aMoon Fund, Alumni Ventures, among 4 total investors. The company has 11-50 employees. Core technologies: Biologicals, Molecules.
With $8M in total funding, MetaSight Diagnostics is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageA
- ProductR&D
- ModelB2B
- Employees11-50
- HQRehovot
- Last Round$8M
- Saban Ventures
- aMoon Fund
- Alumni Ventures
4 investors total
Tomer ShlomiFounder
2 articles covered by sources including www.manilatimes.net,
www.themarker.com.
What does MetaSight Diagnostics do?
MetaSight develops and deploys accurate, affordable, and accessible diagnostics for diverse diseases through a single blood test – applicable for population scale screening. Its approach leverages the world’s largest clinico multi-OMICS database, generated using our proprietary unbiased metabolomics, lipidomics, and proteomics platform.
How much funding has MetaSight Diagnostics raised?
MetaSight Diagnostics has raised $8M in total funding across 2 rounds. The company is currently at the A stage. Key investors include Saban Ventures, aMoon Fund, Alumni Ventures.
Who founded MetaSight Diagnostics?
MetaSight Diagnostics was founded in 2020 by Tomer Shlomi (Founder).
What sector is MetaSight Diagnostics in?
MetaSight Diagnostics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology, Pharmaceuticals.
Where is MetaSight Diagnostics located?
MetaSight Diagnostics is based in Haim Holtsman St, Rehovot, Israel.